BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32713609)

  • 1. Amygdala pathology in amyotrophic lateral sclerosis and primary lateral sclerosis.
    Chipika RH; Christidi F; Finegan E; Li Hi Shing S; McKenna MC; Chang KM; Karavasilis E; Doherty MA; Hengeveld JC; Vajda A; Pender N; Hutchinson S; Donaghy C; McLaughlin RL; Hardiman O; Bede P
    J Neurol Sci; 2020 Oct; 417():117039. PubMed ID: 32713609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Switchboard" malfunction in motor neuron diseases: Selective pathology of thalamic nuclei in amyotrophic lateral sclerosis and primary lateral sclerosis.
    Chipika RH; Finegan E; Li Hi Shing S; McKenna MC; Christidi F; Chang KM; Doherty MA; Hengeveld JC; Vajda A; Pender N; Hutchinson S; Donaghy C; McLaughlin RL; Hardiman O; Bede P
    Neuroimage Clin; 2020; 27():102300. PubMed ID: 32554322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Widespread subcortical grey matter degeneration in primary lateral sclerosis: a multimodal imaging study with genetic profiling.
    Finegan E; Li Hi Shing S; Chipika RH; Doherty MA; Hengeveld JC; Vajda A; Donaghy C; Pender N; McLaughlin RL; Hardiman O; Bede P
    Neuroimage Clin; 2019; 24():102089. PubMed ID: 31795059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brainstem pathology in amyotrophic lateral sclerosis and primary lateral sclerosis: A longitudinal neuroimaging study.
    Bede P; Chipika RH; Finegan E; Li Hi Shing S; Doherty MA; Hengeveld JC; Vajda A; Hutchinson S; Donaghy C; McLaughlin RL; Hardiman O
    Neuroimage Clin; 2019; 24():102054. PubMed ID: 31711033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI data confirm the selective involvement of thalamic and amygdalar nuclei in amyotrophic lateral sclerosis and primary lateral sclerosis.
    Chipika RH; Siah WF; Shing SLH; Finegan E; McKenna MC; Christidi F; Chang KM; Karavasilis E; Vajda A; Hengeveld JC; Doherty MA; Donaghy C; Hutchinson S; McLaughlin RL; Hardiman O; Bede P
    Data Brief; 2020 Oct; 32():106246. PubMed ID: 32944601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical and radiological profile of primary lateral sclerosis: a population-based study.
    Finegan E; Chipika RH; Li Hi Shing S; Doherty MA; Hengeveld JC; Vajda A; Donaghy C; McLaughlin RL; Pender N; Hardiman O; Bede P
    J Neurol; 2019 Nov; 266(11):2718-2733. PubMed ID: 31325016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presymptomatic grey matter alterations in ALS kindreds: a computational neuroimaging study of asymptomatic C9orf72 and SOD1 mutation carriers.
    Bede P; Lulé D; Müller HP; Tan EL; Dorst J; Ludolph AC; Kassubek J
    J Neurol; 2023 Sep; 270(9):4235-4247. PubMed ID: 37178170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Connectivity-based characterisation of subcortical grey matter pathology in frontotemporal dementia and ALS: a multimodal neuroimaging study.
    Bede P; Omer T; Finegan E; Chipika RH; Iyer PM; Doherty MA; Vajda A; Pender N; McLaughlin RL; Hutchinson S; Hardiman O
    Brain Imaging Behav; 2018 Dec; 12(6):1696-1707. PubMed ID: 29423814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and microstructural neuroimaging signature of C9orf72-associated ALS: A multiparametric MRI study.
    Wiesenfarth M; Huppertz HJ; Dorst J; Lulé D; Ludolph AC; Müller HP; Kassubek J
    Neuroimage Clin; 2023; 39():103505. PubMed ID: 37696099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extra-motor cerebral changes and manifestations in primary lateral sclerosis.
    Finegan E; Shing SLH; Chipika RH; Chang KM; McKenna MC; Doherty MA; Hengeveld JC; Vajda A; Pender N; Donaghy C; Hutchinson S; McLaughlin RL; Hardiman O; Bede P
    Brain Imaging Behav; 2021 Oct; 15(5):2283-2296. PubMed ID: 33409820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in somatosensory, visual and auditory pathways in amyotrophic lateral sclerosis: an under-recognised facet of ALS.
    Chipika RH; Mulkerrin G; Murad A; Lope J; Hardiman O; Bede P
    J Integr Neurosci; 2022 Apr; 21(3):88. PubMed ID: 35633169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-sectional and longitudinal assessment of the upper cervical spinal cord in motor neuron disease.
    van der Burgh HK; Westeneng HJ; Meier JM; van Es MA; Veldink JH; Hendrikse J; van den Heuvel MP; van den Berg LH
    Neuroimage Clin; 2019; 24():101984. PubMed ID: 31499409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalamic, hippocampal and basal ganglia pathology in primary lateral sclerosis and amyotrophic lateral sclerosis: Evidence from quantitative imaging data.
    Finegan E; Hi Shing SL; Chipika RH; McKenna MC; Doherty MA; Hengeveld JC; Vajda A; Donaghy C; McLaughlin RL; Hutchinson S; Hardiman O; Bede P
    Data Brief; 2020 Apr; 29():105115. PubMed ID: 32055654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype-associated cerebellar profiles in ALS: focal cerebellar pathology and cerebro-cerebellar connectivity alterations.
    Bede P; Chipika RH; Christidi F; Hengeveld JC; Karavasilis E; Argyropoulos GD; Lope J; Li Hi Shing S; Velonakis G; Dupuis L; Doherty MA; Vajda A; McLaughlin RL; Hardiman O
    J Neurol Neurosurg Psychiatry; 2021 Nov; 92(11):1197-1205. PubMed ID: 34168085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal ganglia involvement in amyotrophic lateral sclerosis.
    Bede P; Elamin M; Byrne S; McLaughlin RL; Kenna K; Vajda A; Pender N; Bradley DG; Hardiman O
    Neurology; 2013 Dec; 81(24):2107-15. PubMed ID: 24212388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippocampal pathology in amyotrophic lateral sclerosis: selective vulnerability of subfields and their associated projections.
    Christidi F; Karavasilis E; Rentzos M; Velonakis G; Zouvelou V; Xirou S; Argyropoulos G; Papatriantafyllou I; Pantolewn V; Ferentinos P; Kelekis N; Seimenis I; Evdokimidis I; Bede P
    Neurobiol Aging; 2019 Dec; 84():178-188. PubMed ID: 31629116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of 18fluorodeoxyglucose-positron-emission tomography in amyotrophic lateral sclerosis: a prospective study.
    Van Laere K; Vanhee A; Verschueren J; De Coster L; Driesen A; Dupont P; Robberecht W; Van Damme P
    JAMA Neurol; 2014 May; 71(5):553-61. PubMed ID: 24615479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identical patterns of cortico-efferent tract involvement in primary lateral sclerosis and amyotrophic lateral sclerosis: A tract of interest-based MRI study.
    Müller HP; Gorges M; Kassubek R; Dorst J; Ludolph AC; Kassubek J
    Neuroimage Clin; 2018; 18():762-769. PubMed ID: 29785360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric MRI study of ALS stratified for the C9orf72 genotype.
    Bede P; Bokde AL; Byrne S; Elamin M; McLaughlin RL; Kenna K; Fagan AJ; Pender N; Bradley DG; Hardiman O
    Neurology; 2013 Jul; 81(4):361-9. PubMed ID: 23771489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amygdala abnormalities across disease stages in patients with sporadic amyotrophic lateral sclerosis.
    Liu S; Zhao Y; Ren Q; Zhang D; Shao K; Lin P; Yuan Y; Dai T; Zhang Y; Li L; Li W; Shan P; Meng X; Wang Q; Yan C
    Hum Brain Mapp; 2022 Dec; 43(18):5421-5431. PubMed ID: 35866384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.